Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-038817
Filing Date
2013-08-01
Accepted
2013-08-01 19:18:43
Documents
1
Period of Report
2013-07-30

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c578199_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c578199_4x0.xml 4 58686
  Complete submission text file 0001209191-13-038817.txt   61239
Mailing Address ONE EMBARCADERO CENTER STE 4000 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER STE 4000 SAN FRANCISCO CA 94111 415-392-7442
Aberdare Ventures III LP (Reporting) CIK: 0001313414 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36003 | Film No.: 131004154

Mailing Address ONE E CENTER STE 4066 SAN FRANCISCO CA 94111
Business Address ONE E CENTER STE 4066 SAN FRANCISCO CA 94111
Aberdare Partners III LP (Reporting) CIK: 0001334248 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36003 | Film No.: 131004153

Mailing Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121
Business Address 4365 EXECUTIVE DRIVE Suite 200 San Diego CA 92121 (858) 558-8130
Conatus Pharmaceuticals Inc (Issuer) CIK: 0001383701 (see all company filings)

EIN.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE EMBARCADERO CENTER, SUITE 4000 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER, SUITE 4000 SAN FRANCISCO CA 94111 (415) 392-7442
Aberdare GP III, L.L.C. (Reporting) CIK: 0001582419 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36003 | Film No.: 131004155